Abstract

Chicken atrophic ovaries have decreased volume and are indicative of ovarian failure, presence of a tumor, or interrupted ovarian blood supply. Ovarian tumor is accompanied by an increase in follicular atresia, granulosa cell (GC) apoptosis, and autophagy. In a previous study, we found using high throughput sequencing that miR-204 is highly expressed in chicken atrophic ovaries. Thus, in the present study, we further investigated its function in GC apoptosis and autophagy. We found that overexpression of miR-204 reduced mRNA and protein levels of proliferation-related genes and increased apoptosis-related genes. Cell counting kit-8 (CCK-8), 5-ethynyl-2-deoxyuridine (EdU), and flow cytometry assays revealed that miR-204 inhibited GC proliferation and promoted apoptosis. Furthermore, we confirmed with reporter gene assays that Forkhead box K2 (FOXK2) was directly targeted by miR-204. FOXK2, as a downstream regulator of phosphoinositide 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signal pathways, promoted GC proliferation and inhibited apoptosis. Subsequently, we observed that miR-204 was involved in GC autophagy by targeting Transient Receptor Potential Melastatin 3 (TRPM3). The luciferase activities of the two binding sites of TRPM3 were decreased in response to treatment with a miR-204 mimic, and the autophagic flux was increased after miR-204 inhibition. However, overexpression of miR-204 had opposite results in autophagosomes and autolysosomes. miR-204 inhibits GC autophagy by suppressing the protein expression of TRPM3/AMP-activated protein kinase (AMPK)/ULK signaling pathway components. Inhibition of miR-204 enhanced autophagy by accumulating and degrading the protein levels of LC3-II (Microtubule Associated Protein Light Chain 3B) and p62 (Protein of 62 kDa), respectively, whereas miR-204 overexpression was associated with contrary results. Immunofluorescence staining showed that there was a significant reduction in the fluorescent intensity of LC3B, whereas p62 protein was increased after TRPM3 silencing. Collectively, our results indicate that miR-204 is highly expressed in chicken atrophic ovaries, which promotes GC apoptosis via repressing FOXK2 through the PI3K/AKT/mTOR pathway and inhibits autophagy by impeding the TRPM3/AMPK/ULK pathway.

Highlights

  • The ovary plays vital roles in female reproductive performance (Castagna et al, 2004; Gethoffer et al, 2018; Zhao et al, 2018) by promoting ovulation and hormone secretion (Sirotkin et al, 2018; Zangirolamo et al, 2018; Russell, 2019)

  • Whole-transcriptome sequencing analysis of atrophic ovaries in broody chickens revealed that miR-204 was expressed differentially between atrophic and normal ovaries

  • The Kyoto Encyclopedia of Genes and Genomes (KEGG) results of target genes revealed that the enriched pathways involved phosphoinositide 3-kinase (PI3K)–Akt signaling, cell cycle, AMPK signaling, and apoptosis

Read more

Summary

Introduction

The ovary plays vital roles in female reproductive performance (Castagna et al, 2004; Gethoffer et al, 2018; Zhao et al, 2018) by promoting ovulation (exocrine function) and hormone secretion (endocrine function) (Sirotkin et al, 2018; Zangirolamo et al, 2018; Russell, 2019). The development and fate of follicles, maturation or atresia, depend on the state of GCs in the follicles. Proliferation of GCs promotes maturation of follicles, while apoptosis led to GC atresia (Matsudaminehata et al, 2006). Abnormal growth and differentiation of GCs cause ovarian diseases, such as premature ovarian failure (Shelling, 2010), polycystic ovarian syndrome (Jiang et al, 2015), and GC tumors (Pilsworth et al, 2018). An atrophic ovary has decreased ovarian tissue volume and is indicative of ovarian failure and interrupted ovarian blood supply, which may affect reproduction in animals. An atrophic ovary will not generate or produce healthy eggs and may affect reproduction (Pilsworth et al, 2018)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call